Name: 글로벌 시장 동향
SKU: BT7376
Availability: InStock

보고서 요약(국문)

개요
글로벌 바이오프로세스 기술 시장은 2022년 YY억 달러에 달했으며, 2023년부터 2030년까지 연평균 성장률(CAGR) YY%로 성장하여 2030년에는 YY백만 달러에 이를 것으로 예상됩니다.
바이오프로세스 기술은 살아있는 세포 또는 그 구성 요소를 이용하여 기질을 원하는 대로 변환하는 생물학적 공정을 산업적으로 응용한 것입니다. 기존 화학 공정에 비해 바이오프로세스의 주요 장점은 온화한 반응 조건에서 진행되며, 더욱 특이적이고 효율적이며, 재생 가능한 부산물(바이오매스)을 생산한다는 점입니다. 재조합 DNA 기술의 개발은 바이오프로세스의 잠재력을 더욱 확장시켰습니다.
바이오프로세스 또는 생명공학은 생물반응기 내에서 효소, 미생물, 식물 세포 또는 동물 세포와 같은 생촉매를 이용하여 의약품, 식품, 향료, 연료 및 화학 물질을 생산하는 데 사용됩니다. 또한 식물, 동물 및 효모, 박테리아, 곰팡이와 같은 미생물을 조작하기 위한 유전자 공학도 포함됩니다.

시장 동향: 성장 동인 및 제약 요인
생명공학 및 제약 기업의 연구 개발 투자 증가
생명공학 및 제약 기업의 연구 개발 투자 증가는 예측 기간 동안 시장 성장을 견인하는 주요 요인 중 하나입니다. 제약 기업들이 생명공학으로 전환하면서 개발 잠재력이 창출되었고, 이에 따라 바이오제약 산업은 의료 및 제약 산업 전반에 걸쳐 입지를 강화했습니다.
예를 들어, 2022년 7월 Biotechnology Report에 실린 한 기사에서는 3D 바이오프린팅, 바이오센서, 유전자 편집과 같은 바이오제약 및 제약 분야의 기술 발전과 최첨단 인공지능, 가상현실 및 증강현실의 도입이 생물공정을 통한 생산 증대 및 가속화를 통해 성장 기회를 창출할 것으로 예상했습니다.
또한, 2022년 10월에는 Oculis SA와 European Biotech Acquisition Corp.가 기업 결합 계약을 체결했다고 발표했습니다. 본 계약은 오큘리스의 차별화된 안과 파이프라인 개발을 가속화하기 위한 것입니다. 이 제품은 당뇨병성 황반부종(DME), 안구건조증(DED), 녹내장과 같은 신경망막 질환 등 의학적 수요가 높은 질환들을 대상으로 하며, 이러한 질환들은 환자 수가 증가하고 있습니다.
또한, 바이오프로세스 기술 연구 개발에 대한 투자 증가가 글로벌 바이오프로세스 시장의 성장을 촉진할 것으로 예상됩니다. 바이오프로세스 기술의 지속적인 발전과 더불어, 각국 정부의 바이오연료 생산 지원 확대는 바이오프로세스 기술 시장의 성장을 더욱 가속화할 것으로 전망됩니다.
시장 동향: 제약 요인
엄격한 규제는 예측 기간 동안 시장 성장을 저해하는 요인 중 하나입니다. 바이오프로세스 기술 분야의 시장 참여자들은 성장 속도를 유지하는 데 어려움을 겪고 있습니다. 전 세계 많은 정부가 이미 규제 조치를 취했으며, 일부 정부는 시장 도구에 대한 높은 비용을 수반하는 강력한 규제 정책을 시행하여 예측 기간 동안 시장 확장을 저해하고 있습니다. 또한, 높은 기술 비용과 숙련된 전문가 부족은 예측 기간 동안 시장 성장을 저해하는 요인입니다.
세그먼트 분석
글로벌 바이오프로세스 기술 시장은 제품 유형, 소모품 및 액세서리, 응용 분야, 최종 사용자 및 지역별로 세분화됩니다.
제품 유형 부문에서 바이오리액터는 시장 점유율의 약 39.2%를 차지했습니다.
제품 유형 부문의 바이오리액터는 약 39.2%를 차지하며 예측 기간 동안 시장을 주도할 것으로 예상됩니다. 바이오리액터는 오염 물질 분해, 식품, 사료, 화학 물질, 의약품, 생의학용 조직 및 장기 생산 등 모든 바이오프로세스에서 필수적인 요소입니다.
예를 들어, 2023년 8월 Sartorius와 Repligen은 Repligen XCell ATF 상류 강화 기술을 Sartorius의 Biostat STR 바이오리액터에 통합한 통합 바이오리액터 시스템을 출시했습니다. 두 회사 모두 목표는 바이오의약품 제조업체를 위해 강화된 종자 배양 및 질소 주입 구현을 간소화하는 것이라고 밝혔습니다.
또한, 2022년 3월 아르헨티나 생명공학 기업인 Stämm Biotech은 1,700만 달러 규모의 시리즈 A 투자 유치를 완료했으며, 이를 통해 차세대 3D 프린팅 생물반응기 개발을 가속화할 수 있을 것으로 알려졌습니다. 이 회사는 자체 개발한 브릭 프린팅 기술(Brick Printing Technology)을 적용한 Sclereid 3D 프린터를 사용하여 미세유체 기반 생물반응기를 개발하고 있습니다. Stämm에 따르면, 이 3D 프린터의 성능은 단 1년 만에 전 세계 바이오의약품 산업에 필요한 생물반응기 설치 용량을 확보하는 데까지 확장될 수 있을 것으로 예상됩니다.
지역 분석
북미는 2022년 시장 점유율의 약 38.4%를 차지했습니다.
북미는 고품질 바이오의약품에 대한 수요 증가와 주요 기업들의 연구 개발 투자 확대에 힘입어 예측 기간 동안 전체 시장 점유율의 약 38.4%를 차지할 것으로 예상됩니다. 더욱이, 생물약품을 치료에 주로 사용하는 만성 질환의 높은 유병률과 이 지역의 잘 구축된 의료 인프라는 산업 성장에 크게 기여했습니다.
예를 들어, 2022년 8월 Beckman Coulter Life Sciences는 Flownamics와 생물공정 배양 모니터링 및 제어를 위한 자동화된 온라인 솔루션 개발을 위한 파트너십을 발표했습니다. 이 자동화 통합은 오류 발생 가능성이 높은 수동 단계를 제거하는 동시에 최대 8개의 생물반응기에 대한 로드 앤 고 샘플 실행, 전자 데이터 관리를 통한 GMP 준수, 원격 워크플로우를 포함한 생존 세포 밀도의 지속적인 제어를 가능하게 합니다.
COVID-19 영향 분석
COVID-19 팬데믹은 전 세계 거의 모든 제조 부문의 공급망에 전례 없는 압박을 가했습니다. 특히 생물공정 및 의료 분야는 공급업체가 COVID-19 백신 및 치료제 수요를 충족할 원자재를 확보하는 데 어려움을 겪으면서 큰 타격을 입었습니다. 기존에 진행 중이던 비 COVID-19 생물학적 제제 프로젝트 생산까지 더해지면서 공급망에 심각한 부담이 가중되었습니다.

시장 세분화
제품 유형별
• 생물반응기
• 계측기
• 생물공정 분석기
• 삼투압계
• 배양기
• 기타
소모품 및 액세서리별
• 배양 배지
• 시약
• 기타
응용 분야별
• 재조합 단백질
• 단클론 항체
• 항생제
• 기타
최종 사용자별
• 바이오제약 회사
• 위탁생산 업체
• 학술 연구 기관
• 기타
지역별
• 북미
o 미국
o 캐나다
o 멕시코
• 유럽
o 독일
o 영국
o 프랑스
o 스페인
o 이탈리아
o 기타 유럽
• 남미
o 브라질
o 아르헨티나
o 기타 남미
• 아시아 태평양
o 중국
o 인도
o 일본
o 호주
o 기타 아시아 태평양
• 중동 및 아프리카
경쟁 환경
생물공정 기술 시장의 주요 글로벌 기업으로는 Thermo Fisher Scientific Inc. 등이 있습니다. 사토리우스, 로슈, 레플리젠, 머크, 솔리다바이오테크, 유니버셀스테크, 어드밴스드 인스트루먼트, 엘리텍그룹, 사이티바 등을 포함한 여러 기업.
주요 개발 사항
 2023년 7월, 고성능 생명과학 솔루션 제공업체인 몰레큘러 디바이스(Molecular Devices, LLC.)는 차세대 신약 개발을 지원하기 위해 오가노이드 라인 확장 서비스를 통해 생물학 산업화를 지속했습니다. 이 서비스는 자체 개발한 생물반응기 및 생물공정 기술을 활용하여 고객이 제공한 오가노이드 라인 또는 환자 유래 이종이식(PDX)에서 유래한 표준화되고 분석 준비가 완료된 오가노이드의 생산을 확대합니다.

 2022년 10월, 팜넥스트 바이오테크(PharmNXT Biotech)는 일회용 생물공정 시스템을 위한 최초의 통합 제조 시설을 공개했습니다. 정부의 핵심 정책인 '메이크 인 인디아(Make in India)'에 발맞춰 뭄바이에 본사를 둔 팜넥스트 바이오테크는 일회용 생물공정 솔루션을 제공하기 위해 푸네에 첫 번째 통합 제조 시설을 설립했습니다. 이 시설은 국내 바이오 의약품 제조의 과제를 해결하기 위해 설립되었습니다.
 2022년 6월, 선도적인 과학 기술 기업인 머크(Merck)는 애질런트 테크놀로지스(Agilent Technologies)와 공정 분석 기술(PAT) 발전을 위한 협력 계약을 체결했다고 발표했습니다. 전 세계 규제 당국에서 강력히 권장하는 PAT는 실시간 출시 및 바이오프로세싱 4.0의 핵심 요소입니다.

보고서 구매 이유:

• 제품 유형, 소모품 및 액세서리, 응용 분야, 최종 사용자 및 지역별 글로벌 바이오프로세스 기술 시장 세분화를 시각화하고 주요 상업 자산 및 기업을 파악합니다.

• 트렌드 분석 및 공동 개발을 통해 사업 기회를 발굴합니다.
• 모든 세그먼트에 대한 다양한 바이오프로세스 기술 시장 수준 데이터가 포함된 엑셀 데이터 시트를 제공합니다.

• 심층적인 질적 인터뷰와 연구를 바탕으로 한 종합적인 분석 결과를 담은 PDF 보고서를 제공합니다.

• 주요 기업의 핵심 제품 정보를 담은 엑셀 파일 형태의 제품 맵핑을 제공합니다.

• 글로벌 바이오프로세스 기술 시장 보고서는 약 69개의 표, 70개의 그림, 그리고 185페이지 분량으로 구성될 예정입니다.
대상 고객 (2023년 기준)
• 제조업체/구매자
• 산업 투자자/투자은행가
• 시장 조사 전문가
• 신흥 기업

보고서 요약(영어 원문)

Overview
Global Bioprocess Technology Market reached US$ YY billion in 2022 and is expected to reach US$ YY million by 2030 growing at a CAGR of YY% during the forecast period 2023-2030.
Bioprocess technology is the industrial application of biological processes involving living cells or their components to effect the desired transformation of substrates. The major advantages of bioprocesses over traditional chemical processes are that they require mild reaction conditions, are more specific and efficient, and produce renewable by-products (biomass). The development of recombinant DNA technology has expanded and extended the potential of bioprocesses.
Bioprocessing or biotechnology is used in the production of pharmaceuticals, foods, flavours, fuels and chemicals with the aid of a biocatalyst such as an enzyme, microorganisms, plant cell, or animal cell in a bioreactor. It also involves genetic engineering for the manipulation of plants, animals, and microorganisms such as yeasts, bacteria and fungi.
Market Dynamics: Drivers and Restraints
Rise in investments in research and development by biotechnology and pharmaceutical companies
The rise in investments in research and development by biotechnology and pharmaceutical companies is one of the key factors that helps the market to grow during the forecast period. Because of the transition of pharmaceutical firms towards biotechnology, which has created development potential, the biopharmaceutical industry has strengthened its roots across the medical and pharmaceutical industries.
For instance, an article published in the Biotechnology Report in July 2022 stated that growing technological developments in biopharmaceutical and pharmaceutical sectors like 3D bioprinting, biosensors, and gene editing, as well as the incorporation of cutting-edge artificial intelligence and virtual and augmented reality, are expected to open growth opportunities by increasing and speeding the production through bioprocessing.
Moreover, in October 2022, Oculis SA and European Biotech Acquisition Corp. reported they had entered into a definitive business combination agreement. This agreement is to accelerate the development of Oculis' differentiated ophthalmology pipeline. This product addresses areas of significant medical need, including diabetic macular edema (DME), dry eye disease (DED), and neuro-retina indications, such as glaucoma, affecting growing patient populations.
Furthermore, an increase in the funding for research and development of bioprocessing technology is estimated to propel the growth of the global bioprocess market. Continuous technological advancements in the bioprocess Moreover, increasing support from the governments of various countries in terms of biofuel production is further expected to drive the growth of the bioprocess technology market.
Market Dynamics: Restraint
Strict regulations are one of the factors that hamper the market growth during the forecast period. The market players in the bioprocess technology sector find it difficult to advance at the growth pace. Many governments around the world have already taken action, and some of them are choosing to impose severe regulation policies backed by the high cost of the market instruments that are preventing the market from expanding during the projected period. Also, the high cost of technology and lack of skilled professionals are the factors that hamper the market growth during the forecast period.
Segment Analysis
The global bioprocess technology is segmented based on product type, consumables and accessories, application, end-user and region.
The bioreactors from the product type segment accounted for approximately 39.2% of the market share
The bioreactors from the product type segment accounted for approximately 39.2 % and it is expected to be dominated during the forecast period. A bioreactor is an indispensable part of any bioprocess irrespective of whether the process degrades pollutants or produces substances such as foods, feeds, chemicals and pharmaceuticals, and tissues and organs for use in biomedicine.
For instance, in August 2023 Sartorius and Repligen launched an integrated bioreactor system that incorporates Repligen XCell ATF upstream intensification technology into Sartorius’ Biostat STR bioreactor. The goal is to simplify intensified seed train and N perfusion implementation for biopharmaceutical manufacturers, according to both companies.
Moreover, in March 2022 Argentinian biotechnology firm Stämm Biotech has reportedly closed a $17 million Series A funding round which will help the company accelerate the development of its next-generation 3D printed bioreactor. The firm is developing its microfluidics-based bioreactor using its proprietary self-developed Brick Printing Technology which powers its Sclereid 3D printer. According to Stämm, the 3D printer’s capabilities could extend to building the installed capacity of bioreactors worldwide for biopharma in just one year.
Geographical Analysis
North America accounted for approximately 38.4% of the market share in 2022
North America is estimated to hold about 38.4% of the total market share throughout the forecast period, owing to the escalating demand for quality biologics and the rising investments in R&D activities by the major players. Moreover, the high prevalence of chronic diseases that mostly use biopharmaceuticals for treatments and the established healthcare infrastructure in the region has significantly contributed to the industry growth.
For instance August 2022 Beckman Coulter Life Sciences announced a partnership with Flownamics to create an automated, online solution for bioprocess culture monitoring and control. This automated integration removes error-prone manual steps while enabling load-and-go sample runs for up to eight bioreactors, GMP compliance with electronic data management, and continuous control of viable cell density, including remote workflows.
COVID-19 Impact Analysis
The COVID-19 pandemic has created unprecedented stress on supply chains in nearly every global manufacturing segment. Bioprocessing and healthcare have been hit especially hard as suppliers struggle to find materials to meet the demand for COVID-19 vaccines and therapeutics. On top of ongoing non-COVID biologics projects being manufactured, this has created serious supply chain stress.
Market Segmentation
By Product Type
• Bioreactors
• Instruments
• Bioprocess Analyzers
• Osmometers
• Incubators
• Others
By Consumables and Accessories
• Culture Media
• Reagents
• Others
By Application
• Recombinant Proteins
• Monoclonal Antibodies
• Antibiotics
• Others
By End-User
• Biopharmaceutical Companies
• Contract Manufacturing Organizations
• Academic Research Institutes
• Others
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o U.K.
o France
o Spain
o Italy
o Rest of Europe
• South America
o Brazil
o Argentina
o Rest of South America
• Asia-Pacific
o China
o India
o Japan
o Australia
o Rest of Asia-Pacific
• Middle East and Africa
Competitive Landscape
The major global players in bioprocess technology market include Thermo Fisher Scientific Inc., Sartorius, Roche, Repligen, Merck, SolidaBiotech, Univercellstech, Advanced Instruments, ELITechGroup Inc, Cytiva and among others.
Key Developments
 In July 2023 Molecular Devices, LLC., a leading high-performance life science solutions provider, continues industrializing biology with its organoid line expansion services to support next-generation drug discovery. The offering leverages proprietary bioreactor and bioprocess technology to scale up the production of standardized, assay-ready organoids originating from customer-supplied organoid lines or patient-derived xenografts (PDX).
 In October 2022 PharmNXT Biotech unveils its first integrated manufacturing unit for single-use bioprocessing systems. In line with 'Make in India', the Government's flagship program, Mumbai-based PharmNXT Biotech launched its first integrated manufacturing unit in Pune to provide single-use bioprocessing solutions. The facility has been launched to address the challenges of biologics manufacturing in the country.
 In June 2022 Merck, a leading science and technology company, announced that it has entered a collaboration with Agilent Technologies to advance Process Analytical Technologies (PAT). PAT, which is strongly encouraged by global regulatory authorities, is a key enabler for real-time release and Bioprocessing 4.0.
Why Purchase the Report?
• To visualize the global bioprocess technology market segmentation-based product type, consumables and accessories, application, end-user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development
• Excel data sheet with numerous bioprocess technology market-level data points with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The global bioprocess technology market report would provide approximately 69 tables, 70 figures, and 185 Pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product Type
3.2. Snippet by Consumables and Accessories
3.3. Snippet by Application
3.4. Snippet by End User
3.5. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Driver
4.1.1.1. Rise in investments in research and development by biotechnology and pharmaceutical companies
4.1.1.2. Rise in the technology advancements
4.1.2. Restraints
4.1.2.1. Regulatory Challenges
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Russia-Ukraine War Impact Analysis
5.6. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Product Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
7.1.2. Market Attractiveness Index, By Product Type
7.2. Bioreactors*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Instruments
7.4. Bioprocess Analyzers
7.5. Osmometers
7.6. Incubators
7.7. Others
8. By Consumables and Accessories
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Consumables and Accessories
8.1.2. Market Attractiveness Index, By Consumables and Accessories
8.2. Culture Media*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Reagents
8.4. Others
9. By Application
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.1.2. Market Attractiveness Index, By Application
9.2. Recombinant Proteins *
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Monoclonal Antibodies
9.4. Antibiotics
9.5. Others
10. By End User
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.1.2. Market Attractiveness Index, By End User
10.2. Biopharmaceutical Companies *
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Contract Manufacturing Organizations
10.4. Academic Research Institutes
10.5. Others
11. By Region
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
11.1.2. Market Attractiveness Index, By Region
11.2. North America
11.2.1. Introduction
11.2.2. Key Region-Specific Dynamics
11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Consumables and Accessories
11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.2.7.1. U.S.
11.2.7.2. Canada
11.2.7.3. Mexico
11.3. Europe
11.3.1. Introduction
11.3.2. Key Region-Specific Dynamics
11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Consumables and Accessories
11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.3.7.1. Germany
11.3.7.2. UK
11.3.7.3. France
11.3.7.4. Italy
11.3.7.5. Spain
11.3.7.6. Rest of Europe
11.4. South America
11.4.1. Introduction
11.4.2. Key Region-Specific Dynamics
11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Consumables and Accessories
11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.4.7.1. Brazil
11.4.7.2. Argentina
11.4.7.3. Rest of South America
11.5. Asia-Pacific
11.5.1. Introduction
11.5.2. Key Region-Specific Dynamics
11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Consumables and Accessories
11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.5.7.1. China
11.5.7.2. India
11.5.7.3. Japan
11.5.7.4. Australia
11.5.7.5. Rest of Asia-Pacific
11.6. Middle East and Africa
11.6.1. Introduction
11.6.2. Key Region-Specific Dynamics
11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Consumables and Accessories
11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12. Competitive Landscape
12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis
13. Company Profiles
13.1. Thermo Fisher Scientific Inc
13.1.1. Company Overview
13.1.2. Product Portfolio and Description
13.1.3. Financial Overview
13.1.4. Key Developments
13.2. Sartorius
13.3. Roche
13.4. Repligen
13.5. Merck
13.6. SolidaBiotech
13.7. Univercellstech
13.8. Advanced Instruments
13.9. ELITechGroup Inc
13.10. Cytiva (LIST NOT EXHAUSTIVE)
14. Appendix
14.1. About Us and Services
14.2. Contact Us

언급된 주요 기업들

Thermo Fisher Scientific Inc, 4.	Key Developments, Sartorius, Roche, Repligen, Merck, SolidaBiotech, Univercellstech, Advanced Instruments, ELITechGroup Inc

표 목록 (Tables)

List of Tables

Table 1 Global Bioprocess Technology Market Value, By Product Type, 2023, 2027 & 2031 (US$ Million)

Table 2 Global Bioprocess Technology Market Value, By Consumables and Accessories, 2023, 2027 & 2031 (US$ Million)

Table 3 Global Bioprocess Technology Market Value, By Application, 2023, 2027 & 2031 (US$ Million)

Table 4 Global Bioprocess Technology Market Value, By End-User, 2023, 2027 & 2031 (US$ Million)

Table 5 Global Bioprocess Technology Market Value, By Region, 2023, 2027 & 2031 (US$ Million)

Table 6 Global Bioprocess Technology Market Value, By Product Type, 2023, 2027 & 2031 (US$ Million)

Table 7 Global Bioprocess Technology Market Value, By Product Type, 2022-2031 (US$ Million)

Table 8 Global Bioprocess Technology Market Value, By Consumables and Accessories, 2023, 2027 & 2031 (US$ Million)

Table 9 Global Bioprocess Technology Market Value, By Consumables and Accessories, 2022-2031 (US$ Million)

Table 10 Global Bioprocess Technology Market Value, By Application, 2023, 2027 & 2031 (US$ Million)

Table 11 Global Bioprocess Technology Market Value, By Application, 2022-2031 (US$ Million)

Table 12 Global Bioprocess Technology Market Value, By End-User, 2023, 2027 & 2031 (US$ Million)

Table 13 Global Bioprocess Technology Market Value, By End-User, 2022-2031 (US$ Million)

Table 14 Global Bioprocess Technology Market Value, By Region, 2023, 2027 & 2031 (US$ Million)

Table 15 Global Bioprocess Technology Market Value, By Region, 2022-2031 (US$ Million)

Table 16 North America Bioprocess Technology Market Value, By Product Type, 2022-2031 (US$ Million)

Table 17 North America Bioprocess Technology Market Value, By Consumables and Accessories, 2022-2031 (US$ Million)

Table 18 North America Bioprocess Technology Market Value, By Application, 2022-2031 (US$ Million)

Table 19 North America Bioprocess Technology Market Value, By End-User, 2022-2031 (US$ Million)

Table 20 North America Bioprocess Technology Market Value, By Country, 2022-2031 (US$ Million)

Table 21 South America Bioprocess Technology Market Value, By Product Type, 2022-2031 (US$ Million)

Table 22 South America Bioprocess Technology Market Value, By Consumables and Accessories, 2022-2031 (US$ Million)

Table 23 South America Bioprocess Technology Market Value, By Application, 2022-2031 (US$ Million)

Table 24 South America Bioprocess Technology Market Value, By End-User, 2022-2031 (US$ Million)

Table 25 South America Bioprocess Technology Market Value, By Country, 2022-2031 (US$ Million)

Table 26 Europe Bioprocess Technology Market Value, By Product Type, 2022-2031 (US$ Million)

Table 27 Europe Bioprocess Technology Market Value, By Consumables and Accessories, 2022-2031 (US$ Million)

Table 28 Europe Bioprocess Technology Market Value, By Application, 2022-2031 (US$ Million)

Table 29 Europe Bioprocess Technology Market Value, By End-User, 2022-2031 (US$ Million)

Table 30 Europe Bioprocess Technology Market Value, By Country, 2022-2031 (US$ Million)

Table 31 Asia-Pacific Bioprocess Technology Market Value, By Product Type, 2022-2031 (US$ Million)

Table 32 Asia-Pacific Bioprocess Technology Market Value, By Consumables and Accessories, 2022-2031 (US$ Million)

Table 33 Asia-Pacific Bioprocess Technology Market Value, By Application, 2022-2031 (US$ Million)

Table 34 Asia-Pacific Bioprocess Technology Market Value, By End-User, 2022-2031 (US$ Million)

Table 35 Asia-Pacific Bioprocess Technology Market Value, By Country, 2022-2031 (US$ Million)

Table 36 Middle East & Africa Bioprocess Technology Market Value, By Product Type, 2022-2031 (US$ Million)

Table 37 Middle East & Africa Bioprocess Technology Market Value, By Consumables and Accessories, 2022-2031 (US$ Million)

Table 38 Middle East & Africa Bioprocess Technology Market Value, By Application, 2022-2031 (US$ Million)

Table 39 Middle East & Africa Bioprocess Technology Market Value, By End-User, 2022-2031 (US$ Million)

Table 40 Thermo Fisher Scientific Inc: Overview

Table 41 Thermo Fisher Scientific Inc: Product Portfolio

Table 42 Thermo Fisher Scientific Inc: Key Developments

Table 43 Sartorius: Overview

Table 44 Sartorius: Product Portfolio

Table 45 Sartorius: Key Developments

Table 46 Roche: Overview

Table 47 Roche: Product Portfolio

Table 48 Roche: Key Developments

Table 49 Repligen: Overview

Table 50 Repligen: Product Portfolio

Table 51 Repligen: Key Developments

Table 52 Merck: Overview

Table 53 Merck: Product Portfolio

Table 54 Merck: Key Developments

Table 55 SolidaBiotech: Overview

Table 56 SolidaBiotech: Product Portfolio

Table 57 SolidaBiotech: Key Developments

Table 58 Univercellstech: Overview

Table 59 Univercellstech: Product Portfolio

Table 60 Univercellstech: Key Developments

Table 61 Advanced Instruments: Overview

Table 62 Advanced Instruments: Product Portfolio

Table 63 Advanced Instruments: Key Developments

Table 64 ELITechGroup Inc: Overview

Table 65 ELITechGroup Inc: Product Portfolio

Table 66 ELITechGroup Inc: Key Developments

Table 67 Cytiva: Overview

Table 68 Cytiva: Product Portfolio

Table 69 Cytiva: Key Developments

그림 목록 (Figures)

List of Figures

Figure 1 Global Bioprocess Technology Market Value, 2022-2031 (US$ Million)

Figure 2 Global Bioprocess Technology Market Share, By Product Type, 2022 & 2031 (%)

Figure 3 Global Bioprocess Technology Market Share, By Consumables and Accessories, 2022 & 2031 (%)

Figure 4 Global Bioprocess Technology Market Share, By Application, 2022 & 2031 (%)

Figure 5 Global Bioprocess Technology Market Share, By End-User, 2022 & 2031 (%)

Figure 6 Global Bioprocess Technology Market Share, By Region, 2022 & 2031 (%)

Figure 7 Global Bioprocess Technology Market Y-o-Y Growth, By Product Type, 2022-2031 (%)

Figure 8 Bioreactors Bioprocess Technology Market Value, 2022-2031 (US$ Million)

Figure 9 Instruments Bioprocess Technology Market Value, 2022-2031 (US$ Million)

Figure 10 Bioprocess Analyzers Bioprocess Technology Market Value, 2022-2031 (US$ Million)

Figure 11 Osmometers Bioprocess Technology Market Value, 2022-2031 (US$ Million)

Figure 12 Incubators Bioprocess Technology Market Value, 2022-2031 (US$ Million)

Figure 13 Others Bioprocess Technology Market Value, 2022-2031 (US$ Million)

Figure 14 Global Bioprocess Technology Market Y-o-Y Growth, By Consumables and Accessories, 2022-2031 (%)

Figure 15 Culture Media Consumables and Accessories in Global Bioprocess Technology Market Value, 2022-2031 (US$ Million)

Figure 16 Reagents Consumables and Accessories in Global Bioprocess Technology Market Value, 2022-2031 (US$ Million)

Figure 17 Others Consumables and Accessories in Global Bioprocess Technology Market Value, 2022-2031 (US$ Million)

Figure 18 Global Bioprocess Technology Market Y-o-Y Growth, By Application, 2022-2031 (%)

Figure 19 Recombinant Proteins Application in Global Bioprocess Technology Market Value, 2022-2031 (US$ Million)

Figure 20 Monoclonal Antibodies Application in Global Bioprocess Technology Market Value, 2022-2031 (US$ Million)

Figure 21 Antibiotics Application in Global Bioprocess Technology Market Value, 2022-2031 (US$ Million)

Figure 22 Others Application in Global Bioprocess Technology Market Value, 2022-2031 (US$ Million)

Figure 23 Global Bioprocess Technology Market Y-o-Y Growth, By End-User, 2022-2031 (%)

Figure 24 Biopharmaceutical Companies End-User in Global Bioprocess Technology Market Value, 2022-2031 (US$ Million)

Figure 25 Contract Manufacturing Organizations End-User in Global Bioprocess Technology Market Value, 2022-2031 (US$ Million)

Figure 26 Academic Research Institutes End-User in Global Bioprocess Technology Market Value, 2022-2031 (US$ Million)

Figure 27 Others End-User in Global Bioprocess Technology Market Value, 2022-2031 (US$ Million)

Figure 28 Global Bioprocess Technology Market Y-o-Y Growth, By Region, 2022-2031 (%)

Figure 29 North America Bioprocess Technology Market Value, 2022-2031 (US$ Million)

Figure 30 Asia-Pacific Bioprocess Technology Market Value, 2022-2031 (US$ Million)

Figure 31 Europe Bioprocess Technology Market Value, 2022-2031 (US$ Million)

Figure 32 South America Bioprocess Technology Market Value, 2022-2031 (US$ Million)

Figure 33 Middle East and Africa Bioprocess Technology Market Value, 2022-2031 (US$ Million)

Figure 34 North America Bioprocess Technology Market Value, 2022-2031 (US$ Million)

Figure 35 North America Bioprocess Technology Market Share, By Product Type, 2022 & 2031 (%)

Figure 36 North America Bioprocess Technology Market Share, By Consumables and Accessories, 2022 & 2031 (%)

Figure 37 North America Bioprocess Technology Market Share, By Application, 2022 & 2031 (%)

Figure 38 North America Bioprocess Technology Market Share, By End-User, 2022 & 2031 (%)

Figure 39 North America Bioprocess Technology Market Share, By Country, 2022 & 2031 (%)

Figure 40 South America Bioprocess Technology Market Value, 2022-2031 (US$ Million)

Figure 41 South America Bioprocess Technology Market Share, By Product Type, 2022 & 2031 (%)

Figure 42 South America Bioprocess Technology Market Share, By Consumables and Accessories, 2022 & 2031 (%)

Figure 43 South America Bioprocess Technology Market Share, By Application, 2022 & 2031 (%)

Figure 44 South America Bioprocess Technology Market Share, By End-User, 2022 & 2031 (%)

Figure 45 South America Bioprocess Technology Market Share, By Country, 2022 & 2031 (%)

Figure 46 Europe Bioprocess Technology Market Value, 2022-2031 (US$ Million)

Figure 47 Europe Bioprocess Technology Market Share, By Product Type, 2022 & 2031 (%)

Figure 48 Europe Bioprocess Technology Market Share, By Consumables and Accessories, 2022 & 2031 (%)

Figure 49 Europe Bioprocess Technology Market Share, By Application, 2022 & 2031 (%)

Figure 50 Europe Bioprocess Technology Market Share, By End-User, 2022 & 2031 (%)

Figure 51 Europe Bioprocess Technology Market Share, By Country, 2022 & 2031 (%)

Figure 52 Asia-Pacific Bioprocess Technology Market Value, 2022-2031 (US$ Million)

Figure 53 Asia-Pacific Bioprocess Technology Market Share, By Product Type, 2022 & 2031 (%)

Figure 54 Asia-Pacific Bioprocess Technology Market Share, By Consumables and Accessories, 2022 & 2031 (%)

Figure 55 Asia-Pacific Bioprocess Technology Market Share, By Application, 2022 & 2031 (%)

Figure 56 Asia-Pacific Bioprocess Technology Market Share, By End-User, 2022 & 2031 (%)

Figure 57 Asia-Pacific Bioprocess Technology Market Share, By Country, 2022 & 2031 (%)

Figure 58 Middle East & Africa Bioprocess Technology Market Value, 2022-2031 (US$ Million)

Figure 59 Middle East & Africa Bioprocess Technology Market Share, By Product Type, 2022 & 2031 (%)

Figure 60 Middle East & Africa Bioprocess Technology Market Share, By Consumables and Accessories, 2022 & 2031 (%)

Figure 61 Middle East & Africa Bioprocess Technology Market Share, By Application, 2022 & 2031 (%)

Figure 62 Middle East & Africa Bioprocess Technology Market Share, By End-User, 2022 & 2031 (%)

Figure 63 Thermo Fisher Scientific Inc: Financials

Figure 64 Sartorius: Financials

Figure 65 Roche: Financials

Figure 66 Repligen: Financials

Figure 67 Merck: Financials

Figure 68 SolidaBiotech: Financials

Figure 69 Univercellstech: Financials

Figure 70 Advanced Instruments: Financials

Figure 71 ELITechGroup Inc: Financials

Figure 72 Cytiva: Financials

글로벌 바이오프로세스 기술 시장 – 2023-2030

Global Bioprocess Technology Market - 2023-2030